During the past decade, Gangnam Severance Hospital conducted 198 clinical trials. In the 10-year time frame, 198 clinical trials started and 37 clinical trials were completed, i.e. on average, 18.7% percent of trials that started reached the finish line to date. In the past 5 years, 94 clinical trials started and 24 clinical trials were completed. i.e. 25.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gangnam Severance Hospital" #1 sponsor was "Gangnam Severance Hospital" with 57 trials, followed by "Yonsei University" with 29 trials sponsored, "Hoffmann-La Roche" with 16 trials sponsored, "Seung-Jung Park" with 13 trials sponsored and "Seoul National University Hospital" with 13 trials sponsored. Other sponsors include 164 different institutions and companies that sponsored additional 103 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gangnam Severance Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 13 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Severance Hospital" with 6 trials as a collaborator and "Asan Medical Center" with 5 trials as a collaborator. Other collaborators include 108 different institutions and companies that were collaborators in the rest 91 trials.

According to Clinical.Site data, the most researched conditions in "Gangnam Severance Hospital" are "Breast Cancer" (18 trials), "Coronary Artery Disease" (16 trials), "Gastric Cancer" (10 trials), "Hypertension" (8 trials) and "Cervical Cancer" (7 trials). Many other conditions were trialed in "Gangnam Severance Hospital" in a lesser frequency.

Most popular intervention types in "Gangnam Severance Hospital" are "Drug" (187 trials), "Procedure" (41 trials), "Device" (38 trials), "Other" (28 trials) and "Biological" (22 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Paclitaxel" (15 trials), "Carboplatin" (11 trials), "Quality-of-Life Assessment" (8 trials) and "Laboratory Biomarker Analysis" (7 trials). Other intervention names were less common.

The vast majority of trials in "Gangnam Severance Hospital" are 246 trials for "All" genders, 42 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Gangnam Severance Hospital". 2 are not yet recruiting, 49 are recruiting, 37 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 131 completed trials in Gangnam Severance Hospital, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Gangnam Severance Hospital, 16 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 42 trials, and there were also 65 trials that are defined as “Not Applicable".